• Featured Product
  • KD/KO Validated

PIR Polyclonal antibody

PIR Polyclonal Antibody for IP, WB,ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IP,ELISA

Conjugate

Unconjugated

Cat no : 10263-1-AP

Synonyms

PIR, Pirin



Tested Applications

Positive WB detected inHepG2 cells, HeLa cells
Positive IP detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

10263-1-AP targets PIR in WB, IP,ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen PIR fusion protein Ag0330
Full Name pirin (iron-binding nuclear protein)
Calculated Molecular Weight 32 kDa
Observed Molecular Weight 35 kDa
GenBank Accession NumberBC002517
Gene Symbol PIR
Gene ID (NCBI) 8544
RRIDAB_2283879
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Pirin (iron-binding nuclear protein, PIR) is a highly conserved 32-kDa protein consisting of 290 amino acids. Pirin mRNA is expressed weakly in all human tissues. Confocal immunofluorescence experiments demonstrate a predominant localization of Pirin within dot-like subnuclear structures. Pirin interacts with the oncoprotein B-cell lymphoma 3-encoded (Bcl-3) and nuclear factor I (NFI).

Protocols

Product Specific Protocols
WB protocol for PIR antibody 10263-1-APDownload protocol
IP protocol for PIR antibody 10263-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Cell Cycle

PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1.

Authors - Muhammad Suleman
  • KD Validated